Nanodelivery of triamcinolone acetonide with PLGA-chitosan nanoparticles for the treatment of ocular inflammation

References

• WHO. Priority eye diseases; 2010; [cited 2019 Jul 15]. Available from: http://www.who.int/blindness/causes/priority/en/index1.html
   Google Scholar
• WHO. Visual impairment and blindness; 2014; [cited 2019 Jul 10]. Available from: http://www.who.int/mediacentre/factsheets/fs282/en/
   Google Scholar
• Khairallah M, Kahloun R, Bourne R, et al. Number of people blind or visually impaired by cataract worldwide and in world regions, 1990 to 2010. Invest Ophthalmol Vis Sci. 2015;56(11):6762–6910.
   PubMed Web of Science ®Google Scholar
• Harding JJ. Viewing molecular mechanisms of ageing through a lens. Ageing Res Rev. 2002;1(3):465–479.
   PubMed Web of Science ®Google Scholar
• Pescosolido N, Barbato A, Giannotti R, et al. Age-related changes in the kinetics of human lenses: prevention of the cataract. Int J Ophthalmol. 2016;9:1506–1710.
   PubMed Web of Science ®Google Scholar
• Prokofyeva E, Wegener A, Zrenner E. Cataract prevalence and prevention in Europe: a literature review. Acta Ophthalmol. 2013;91(5):395–405.
   PubMed Web of Science ®Google Scholar
• Abraldes MJ, Fernandez M, Gomez-Ulla F. Intravitreal triamcinolone in diabetic retinopathy. Curr Diabetes Rev. 2009;5(1):18–25.
   PubMedGoogle Scholar
• Degenring R, Jonas J. Intravitreal injection of triamcinolone acetonide as treatment for chronic uveitis. Br J Ophthalmol. 2003;87(3):361.
   PubMed Web of Science ®Google Scholar
• Chen H, Sun S, Li J, et al. Different intravitreal properties of three triamcinolone formulations and their possible impact on retina practice. Invest Ophthalmol Vis Sci. 2013;54(3):2178–2185.
   PubMed Web of Science ®Google Scholar
• Smithen LM, Ober MD, Maranan L, et al. Intravitreal triamcinolone acetonide and intraocular pressure. Am J Ophthalmol. 2004;138(5):740–743.
   PubMed Web of Science ®Google Scholar
• Choy YB, Prausnitz MR. The rule of five for non-oral routes of drug delivery: ophthalmic, inhalation and transdermal. Pharm Res. 2011;28(5):943–948.
   PubMed Web of Science ®Google Scholar
• Cekic O, Chang S, Tseng JJ, et al. Cataract progression after intravitreal triamcinolone injection. Am J Ophthalmol. 2005;139(6):993–998.
   PubMed Web of Science ®Google Scholar
• Quiram PA, Gonzales CR, Schwartz SD. Severe steroid-induced glaucoma following intravitreal injection of triamcinolone acetonide. Am J Ophthalmol. 2006;141(3):580–582.
   PubMed Web of Science ®Google Scholar
• Araújo J, Gonzalez E, Egea MA, et al. Nanomedicines for ocular NSAIDs: safety on drug delivery. Nanomedicine. 2009;5(4):394–401.
   PubMed Web of Science ®Google Scholar
• Wong CW, Metselaar JM, Storm G, et al. A review of the clinical applications of drug delivery systems for the treatment of ocular anterior segment inflammation. Br J Ophthalmol. 2020.
   Google Scholar
• Ramasamy T, Ruttala HB, Gupta B, et al. Smart chemistry-based nanosized drug delivery systems for systemic applications: a comprehensive review. J Control Release. 2017;258:226–253.
   PubMed Web of Science ®Google Scholar
• Jian HJ, Wu RS, Lin TY, et al. Super-cationic carbon quantum dots synthesized from spermidine as an eye drop formulation for topical treatment of bacterial keratitis. ACS Nano. 2017;11(7):6703–6716.
   PubMed Web of Science ®Google Scholar
• Luo LJ, Lin TY, Yao CH, et al. Dual-functional gelatin-capped silver nanoparticles for antibacterial and antiangiogenic treatment of bacterial keratitis. J Colloid Interface Sci. 2019;536:112–126.
   PubMed Web of Science ®Google Scholar
• Li YJ, Luo LJ, Harroun SG, et al. Synergistically dual-functional nano eye-drops for simultaneous anti-inflammatory and anti-oxidative treatment of dry eye disease. Nanoscale. 2019;11(12):5580–5594.
   PubMed Web of Science ®Google Scholar
• Manzoor AA, Lindner LH, Landon CD, Park JY, Simnick AJ, Dreher MR, Das S, Hanna G, Park W, Chilkoti A, Koning GA, ten Hagen TL, Needham D, Dewhirst MW. Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors. Cancer Res. 2012 Nov 1;72(21):5566–75. doi: https://doi.org/10.1158/0008-5472.CAN-12-1683.
   PubMed Web of Science ®Google Scholar
• Luo LJ, Nguyen DD, Lai JY. Dually functional hollow ceria nanoparticle platform for intraocular drug delivery: a push beyond the limits of static and dynamic ocular barriers toward glaucoma therapy. Biomaterials. 2020;243:119961.
   PubMed Web of Science ®Google Scholar
• Danhier F, Ansorena E, Silva JM, et al. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release. 2012;161(2):505–522.
   PubMed Web of Science ®Google Scholar
• Stevanovic M, Uskokovic D. Poly(lactide-co-glycolide)-based micro and nanoparticles for the controlled drug delivery of vitamins. Curr Nanosci. 2009;5(1):1–14.
   Web of Science ®Google Scholar
• Nguyen DD, Luo LJ, Lai JY. Effects of shell thickness of hollow poly(lactic acid) nanoparticles on sustained drug delivery for pharmacological treatment of glaucoma. Acta Biomater. 2020;111:302–315.
   PubMed Web of Science ®Google Scholar
• Lu B, Lv X, Le Y. Chitosan-modified PLGA nanoparticles for control-released drug delivery. Polymers (Basel). 2019;11(2):304.
   PubMed Web of Science ®Google Scholar
• Zou P, Yang X, Wang J, et al. Advances in characterisation and biological activities of chitosan and chitosan oligosaccharides. Food Chem. 2016;190:1174–1181.
   PubMed Web of Science ®Google Scholar
• Huang WF, Tsui CP, Tang CY, et al. Surface charge switchable and pH-responsive chitosan/polymer core–shell composite nanoparticles for drug delivery application. Compos Part B Eng. 2017;121:83–91.
   Web of Science ®Google Scholar
• Ramasamy T, Haidar ZS, Tran TH, et al. Layer-by-layer assembly of liposomal nanoparticles with PEGylated polyelectrolytes enhances systemic delivery of multiple anticancer drugs. Acta Biomater. 2014;10(12):5116–5127.
   PubMed Web of Science ®Google Scholar
• Ramasamy T, Munusamy S, Ruttala HB, et al. Smart nanocarriers for the delivery of nucleic acid-based therapeutics: a comprehensive review. Biotechnol J. 2021;16(2):e1900408.
   PubMed Web of Science ®Google Scholar
• Ramasamy T, Ruttala HB, Kaliraj K, et al. Polypeptide derivative of metformin with the combined advantage of a gene carrier and anticancer activity. ACS Biomater Sci Eng. 2019;5(10):5159–5168.
   PubMed Web of Science ®Google Scholar
• Narayanan R, Mungcal JK, Kenney MC, et al. Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithelial cells. Invest Ophthalmol Vis Sci. 2006;47(2):722–728.
   PubMed Web of Science ®Google Scholar
• Gallarate M, Chirio D, Bussano R, et al. Development of O/W nanoemulsions for ophthalmic administration of timolol. Int J Pharm. 2013;440(2):126–134.
   PubMed Web of Science ®Google Scholar
• Abdullah TA, Ibrahim NJ, Warsi MH. Chondroitin sulfate-chitosan nanoparticles for ocular delivery of bromfenac sodium: improved permeation, retention, and penetration. Int J Pharm Investig. 2016;6(2):96–105.
   PubMed Web of Science ®Google Scholar
• Calles JA, Lopez-Garcia A, Valles EM, et al. Preliminary characterization of dexamethasone-loaded cross-linked hyaluronic acid films for topical ocular therapy. Int J Pharm. 2016;509(1–2):237–243.
   PubMed Web of Science ®Google Scholar